DNA

GINKGO BIOWORKS HOLDINGS INC

DNA·37611X209·US·Common Stock·Healthcare - Biotechnology-13D/G

DNA (GINKGO BIOWORKS HOLDINGS INC) is held by 100 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($42.4M), VIKING GLOBAL INVESTORS LP ($35.4M), Erste Asset Management GmbH ($25.9M). Net institutional sentiment: Bullish.

100
Holders
(10 Elite)
$304.5M
Total Value
68% (94)
Consensus
64 buying - 30 selling
13F: Insider & Congress: Updated regularly
DNA

Smart Money Verdict

View all
Loading verdict
Held by 100 funds
10 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 25, 2026 · Activists Jul 30, 2026 · Congress none

InsiderCPCoen Steven P.Sell $2KAug 24, 2026
InsiderCPCoen Steven P.Exercise 156 shAug 21, 2026
InsiderCPCoen Steven P.Exercise 587 shAug 21, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
4.3M(+17.6%)$42.4M0.0%-25.87%
34
Unchanged
3.6M$35.4M0.1%-94.23%
0
Increased
2.5M(+30.3%)$25.9M0.2%-67.87%
43
Unchanged
2.4M$23.7M0.0%-97.36%
0
Increased
2.1M(+9.0%)$20.7M0.0%+3.79%
31
Increased
1.7M(+0.5%)$16.5M0.0%-61.24%
28
Increased
1.5M(+9.3%)$14.6M0.0%-59.43%
31
Increased
1.2M(+21.1%)$12.1M0.0%-87.72%
33
Increased
937,803(+65.8%)$9.3M0.0%-9.33%
40
Increased
785,798(+12.2%)$7.8M0.0%-20.73%
31
Increased
691,659(+18.7%)$6.9M0.0%-24.42%
32
Increased
638,676(+30.9%)$6.3M0.0%-6.96%
34
Increased
621,625(+110.9%)$6.2M0.0%-17.09%
44
Unchanged
610,729$6.1M0.1%-89.30%
0
Decreased
607,376(-34.7%)$6M0.0%-19.01%
0
Increased
545,852(+14.5%)$5.4M0.0%-23.91%
31
Increased
539,856(+437.4%)$5.3M0.0%-22.36%
44
Increased
405,141(+21.2%)$4M0.0%-82.06%
32
Increased
394,607(+18.7%)$3.9M0.0%-92.17%
31
Increased
358,783(+11.4%)$3.6M0.0%-63.51%
30

Showing 1-20 of 106

1 / 6
DNADNAGINKGO BIOWORKS HOLDINGS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used